YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Patient 2

15-Month Follow-up After YUTIQ Treatment

Presentation at 15-Month Follow-up

IOP15 mmHg
Vitreous cellClear
Fundus exam findingsERM stable
Continue to monitor for IOP elevations and inflammation recurrence.

Imaging at 15-Month Follow-up